2024-11-24 07:53:36
SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy
Health/ 2023-07-22
SNIPR Biome reports positive clinical in...

SNIPR001 demonstrates proof of principle in reducing E. coli levels in the human gastrointestinal tract

Caliway Biopharmaceuticals Announces Initiation of Subject Recruitment in CBL-0204 Phase 2b Study Evaluating the Efficacy of CBL-514 in Abdominal Subcutaneous Fat Reduction
Corporate/ 2023-07-24
Caliway Biopharmaceuticals Announces Ini...

- Caliway has initiated the subject recruitment in CBL-0204 Phase 2b study. - The study is expected to be completed in Q2 2024,and the topli...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release